Richard Kerr

Richard Kerr

Sanofi US - New Jersey / United States
Natural Sciences / Chemical Sciences
AD Scientific Index ID: 4456976
-
person_outline Richard Kerr's MOST POPULAR ARTICLES
1-) Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer’s diseaseMW Beck, JS Derrick, RA Kerr, SB Oh, WJ Cho, SJC Lee, Y Ji, J Han, ...Nature communications 7 (1), 1-13, 2016752016
2-) A rationally designed small molecule for identifying an in vivo link between metal–amyloid-β complexes and the pathogenesis of Alzheimer\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s diseaseMW Beck, SB Oh, RA Kerr, HJ Lee, SH Kim, S Kim, M Jang, BT Ruotolo, ...Chemical Science 6 (3), 1879-1886, 2015702015
3-) A redox-active, compact molecule for cross-linking amyloidogenic peptides into nontoxic, off-pathway aggregates: In vitro and in vivo efficacy and molecular mechanismsJS Derrick, RA Kerr, Y Nam, SB Oh, HJ Lee, KG Earnest, N Suh, KL Peck, ...Journal of the American Chemical Society 137 (46), 14785-14797, 2015642015
4-) Sizing up protein–ligand complexes: the rise of structural mass spectrometry approaches in the pharmaceutical sciencesJD Eschweiler, R Kerr, J Rabuck-Gibbons, BT RuotoloAnnual Review of Analytical Chemistry 10 (1), 25-44, 2017612017
5-) Structural dynamics associated with intermediate formation in an archetypal conformational diseaseMP Nyon, L Segu, LD Cabrita, GR Lévy, J Kirkpatrick, BD Roussel, ...Structure 20 (3), 504-512, 2012362012